Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.935 USD | +4.03% | +1.84% | -2.76% |
May. 14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
May. 13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.76% | 32.28M | |
+16.75% | 83.47B | |
-31.68% | 69.72B | |
-3.24% | 26.37B | |
+4.13% | 17.86B | |
-13.17% | 16.83B | |
+0.96% | 15.7B | |
+73.66% | 13.45B | |
+72.40% | 12.81B | |
-3.03% | 12.44B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Earnings Flash (XGN) EXAGEN Reports Q1 Revenue $14.4M, vs. Street Est of $13.1M